Insider trades
Mats Wahlstrom, Director of Coherus Oncology CHRS, has filed 4 purchases and 1 sale on the open market. Over the past 12 months that comes to a net purchase of $151.8K. The latest trade was on 06/05.
Mats Wahlstrom
Director
- Company
- Coherus Oncology CHRS
- First filing
- 23/06/09
- Trades
- 24 trades
- Buys / sales
- 4 / 1
- 12-month net buying
- $151.8K
- Last trade
- 06/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 05/15 | 05/18 | 60,000 sh | $2.53 | $151,800 | +68.5% | |
Coherus OncologyCHRS | Open-market sale | 25/05/23 | 25/05/28 | 99,988 sh | $0.74 | $73,991.12 | −100.0% |
| Open-market buy | 24/11/22 | 24/11/25 | 5,000 sh | $4.55 | $22,750 | +46.6% | |
TLSI | Open-market buy | 24/11/20–24/11/21 | 24/11/22 | 10,727 sh2 trades | $4.39avg. | $47,056.68 | No record |
